Genomics

New research challenges long-held beliefs, revealing a high-risk subset in "safe" tumors and a surprising link between body weight and cancer recurrence.

A landmark study reveals a hidden genetic cause for a common kidney disease in adults, urging for expanded genetic screening and paving the way for new therapies.

Leveraging space-age ferrofluid tech, Ferrotec's new Ferrobeads aim to free labs from costly proprietary systems with a flexible, high-efficiency solution.

A $500K grant accelerates a novel therapy that dismantles tumor defenses, offering new hope for patients with hard-to-treat gastroesophageal cancers.

A new powerhouse residency program backed by Silicon Valley elite launches near Stanford to turn academic science into fundable healthcare companies.

A new AI-driven platform moves beyond static reports, offering continuous genomic updates to give cancer patients access to the latest treatment options.

ATCC and the Broad Institute unveil engineered lung cancer cells to decode drug resistance, offering new hope for patients and fueling AI-driven discovery.

A landmark conference merges top organizations to accelerate research on retinal diseases, from gene editing to AI, offering new hope for millions worldwide.

After a decade as Semaphore Solutions, Labbit is going all-in on its LIMS platform. Here’s why the strategic shift matters for regulated laboratories.

A Japanese startup’s ultra-fast genome accelerator joins a national AI program, aiming to slash sequencing time and democratize advanced healthcare.

Patients, doctors, and researchers unite for a grueling ride across Iceland, raising funds and hope for a future free from multiple myeloma.

Quintara Biosciences launches AmpValue, a $4.99 overnight sequencing service set to disrupt biotech by making advanced, full-length data accessible to all.

A new service from Alida Biosciences simultaneously reads three key RNA modifications, opening a new frontier in disease diagnostics and biological research.

Atelerix's revolutionary hydrogel eliminates the need for cold chain logistics, partnering with JH Health to unlock the booming Saudi biotech market.

As scientific innovation in oncology accelerates, a new bottleneck emerges: bringing discoveries to market. Specialized firms are now crucial guides.

The Jackson Laboratory appoints Steven Holstein to bridge science and capital, supercharging its new integrated platform for developing breakthrough therapies.

A single-dose therapy wiped out aggressive glioblastoma tumors in a landmark pre-clinical study, paving the way for human trials in 2026.

AIRNA has dosed the first patient with AIR-001, an RNA-editing drug that could treat both the lung and liver damage of a devastating genetic disease.

TriNetX's acquisition of Zetta Genomics' XetaBase platform promises to accelerate research by integrating genomic and clinical data on a global scale.

A new clinical trial uses multi-ancestry genetic risk scores to see if knowing your DNA can motivate you to prevent heart disease. Here's how it works.